Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?

Key Points Eli Lilly is at the forefront of the GLP-1 weight loss drug market. The company's leading position is already being tested by Novo Nordisk's GLP-1 weight loss pill. Merck and Bristol Myers Squibb have largely been forgotten by investors. 10 stocks we like better than Bristol Myers Squibb › Over short periods, Wall Street is driven by emotions. Over the long term, fundamentals start to matter. Right now, investors are extremely excited about GLP-1 weight loss drugs. That focus has Eli L ...